Targeted nanoscale therapeutics for myocardial infarction

Holly L. Sullivan, Nathan C. Gianneschi, Karen L. Christman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Nanoscale therapeutics have promise for the administration of therapeutic small molecules and biologics to the heart following myocardial infarction. Directed delivery to the infarcted region of the heart using minimally invasive routes is critical to this promise. In this review, we will discuss the advances and design considerations for two nanoscale therapeutics engineered to target the infarcted heart, nanoparticles and adeno-Associated viruses. This journal is

Original languageEnglish (US)
Pages (from-to)1204-1216
Number of pages13
JournalBiomaterials Science
Issue number4
StatePublished - Feb 21 2021

ASJC Scopus subject areas

  • Biomedical Engineering
  • Materials Science(all)


Dive into the research topics of 'Targeted nanoscale therapeutics for myocardial infarction'. Together they form a unique fingerprint.

Cite this